  Genomics has become an essential technology for surveilling emerging
infectious disease outbreaks. A wide range of technologies and strategies for
pathogen genome enrichment and sequencing are being used by laboratories
worldwide, together with different, and sometimes ad hoc, analytical procedures
for generating genome sequences. As a result, public repositories now contain
non-standard entries of varying quality. A standardized analytical process for
consensus genome sequence determination, particularly for outbreaks such as the
ongoing COVID-19 pandemic, is critical to provide a solid genomic basis for
epidemiological analyses and well-informed decision making. To address this
need, we have developed a bioinformatic workflow to standardize the analysis of
SARS-CoV-2 sequencing data generated with either the Illumina or Oxford
Nanopore platforms. Using an intuitive web-based interface, this workflow
automates SARS-CoV-2 reference-based genome assembly, variant calling, lineage
determination, and provides the ability to submit the consensus sequence and
necessary metadata to GenBank or GISAID. Given a raw Illumina or Oxford
Nanopore FASTQ read file, this web-based platform enables non-bioinformatics
experts to automatically produce a SARS-CoV-2 genome that is ready for
submission to GISAID or GenBank.
  Availability:https://edge-covid19.edgebioinformatics.org;https://github.com/LANL-Bioinformatics/EDGE/tree/SARS-CoV2
